KRISTEN LIDGETT: Open Payments
NPI 1093209744 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,546 in 88 payments from 20 companies in 2025. Trend: 2023 $1,487 · 2024 $1,549 · 2025 $1,546
Food & beverage: $1,546
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $239 |
| AstraZeneca Pharmaceuticals LP | 8 | $221 |
| GlaxoSmithKline, LLC. | 14 | $177 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $166 |
| Novo Nordisk Inc | 9 | $158 |
| Otsuka America Pharmaceutical, Inc. | 6 | $129 |
| Lilly USA, LLC | 4 | $67 |
| Exact Sciences Corporation | 2 | $55 |
| Amgen Inc. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $45 |
Products named: XIFAXAN, TRELEGY ELLIPTA, NURTEC ODT, REXULTI, FARXIGA, Wegovy, JARDIANCE, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
